Brief: Zealand Pharma Fy Revenue Up At DKK 9,215 Million

Zealand Pharma A/S

19/02/2026 06:13

Feb 19 (Reuters) - Zealand Pharma A/S ZELA.CO:

2026 OUTLOOK: NET OPERATING EXPENSES, EXCLUDING. OOI DKK 2,700 - 3,300 MILLION

FY OPERATING RESULT DKK 6,959 MILLION

FY REVENUE DKK 9,215 MILLION

Source text: ID:nGNE9G69sX

Further company coverage: ZELA.CO

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com;  +48 58 769 66 00;))